Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
about
Clinical trials on corticosteroids for diabetic macular edemaPretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedemaCurrent treatment approaches in diabetic macular edema.Pharmacotherapies for diabetic retinopathy: present and future.Acute orbital abscess complicating deep posterior subtenon triamcinolone injectionComparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema.Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema.Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series.Subtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese populationIntravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.Periocular corticosteroid injections in uveitis: effects and complications.Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Drug safety evaluation of intravitreal triamcinolone acetonide.Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection.Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization.Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.Intravitreal steroids for the treatment of retinal diseases
P2860
Q31146864-22CF1B2F-8A39-4824-A6FF-16324F6F13A4Q33262296-3E750A51-24C0-4FD4-828B-F02FD84FD4FDQ33279749-398F7FCA-A148-4EAF-977A-03BF1984D91CQ33294882-9135BCE0-3F1A-4E5F-9912-BC2D66741338Q33328788-A9159617-2CC1-4F75-98CF-9DC67035CB34Q33395775-F769032C-72D7-4ED8-A864-16BD5DF858A8Q33706098-FE37863F-CC6F-469C-989F-32FB44645FE1Q33719062-8D9AC72B-0832-427E-8230-6D4BB0A6B4F4Q33841803-3987B6C8-B31B-44EB-B6B1-89449919D1A5Q33900514-B847E02E-DDF3-49A3-A8FA-3CC24770E6A2Q34001902-4BC06237-2B8E-46AD-9A66-C7C70779FC1FQ34015028-397D6C1B-DEFB-49AC-8A4A-2F0572B82565Q34336983-93B54B1E-BF1E-48EA-860C-79B4FD517AEDQ34624389-F932FD15-16F8-4C50-9C89-D204546CB19AQ35097904-7D55F01E-9ACE-49E3-A409-D2018EB2DC00Q36548120-662CADEC-8137-4653-84D7-3FD92EE5A65EQ36769325-D51CAF87-54C0-4734-9FB0-0A1839B377AAQ37477129-0FB5B3EF-2E6E-4EDE-8885-B74A1C1A2FE3Q37953969-A4B62F51-4E73-46E7-A59B-164BA48A79A0Q40839421-1B7BFF8A-7936-4042-8E73-9F187B250463Q42339090-18948F2D-846C-4271-8A61-4AA02B7CB1E2Q45935983-0C7EF5B6-FBEB-4A96-8FF3-F80F6ECCA4E3Q46739572-4DA914FD-54A8-44A3-A14D-3FE57AE47046Q47654688-B7A44119-87DD-4C69-97E1-17BC94FF2440Q48078069-13EAD07A-CF62-4107-933D-0EC804495BE8Q50058039-6DF904D8-25CB-4382-9088-1C34697E4D51Q51701226-9370CFA1-7387-46E7-8040-3CC629F5D055Q59101228-22FDCE32-6435-4F48-B3C2-B2F921EC026F
P2860
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
@ast
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
@en
type
label
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
@ast
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
@en
prefLabel
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
@ast
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
@en
P1476
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema
@en
P2093
Sophie J Bakri
P304
P356
10.1016/J.AJO.2004.09.038
P407
P577
2005-02-01T00:00:00Z